Pegfilgrastim vs. Filgrastim - Comparison of Mobilized Blood Stem Cells in Patients With Non Hodgkin-lymphoma

• Status: Completed
• Trial end date: 2011-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the ability of pegfilgrastim vs. filgrastim to mobilize peripheral blood stem cells in patients with Non Hodgkin-lymphoma in an intraindividual study

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital Tuebingen
• Treatments: Lenograstim

Criteria

Inclusion Criteria:

• histological diagnosis of non-Hodgkin lymphoma

• planned high-dose therapy with autologous stem cell transplantation

• WHO performance status 0-2

• written consent

Exclusion Criteria:

• allergy against (peg)filgrastim

• life expectancy <3 months

• other malignant diseases within the last 5 years

• cardial insufficiency (>= New York Heart Association II°)

• uncontrolled infection

• pregnancy, lactation

• central nervous system lymphoma

• Karnofsky score <70%